Journal article 1266 views
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
Diabetes, Obesity and Metabolism, Volume: 16, Issue: 7, Pages: 588 - 601
Swansea University Author:
David Owens
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1111/dom.12253
Abstract
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
| Published in: | Diabetes, Obesity and Metabolism |
|---|---|
| Published: |
2014
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa26727 |
| first_indexed |
2016-03-10T02:00:07Z |
|---|---|
| last_indexed |
2018-02-09T05:09:01Z |
| id |
cronfa26727 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2017-03-07T16:07:51.6513816</datestamp><bib-version>v2</bib-version><id>26727</id><entry>2016-03-09</entry><title>Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus</title><swanseaauthors><author><sid>2fd4b7c3f82c6d3bd546eff61ff944e9</sid><ORCID>0000-0003-1002-1238</ORCID><firstname>David</firstname><surname>Owens</surname><name>David Owens</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2016-03-09</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes, Obesity and Metabolism</journal><volume>16</volume><journalNumber>7</journalNumber><paginationStart>588</paginationStart><paginationEnd>601</paginationEnd><publisher/><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2014</publishedYear><publishedDate>2014-12-31</publishedDate><doi>10.1111/dom.12253</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2017-03-07T16:07:51.6513816</lastEdited><Created>2016-03-09T14:12:01.7325402</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>G. B.</firstname><surname>Bolli</surname><order>1</order></author><author><firstname>D. R.</firstname><surname>Owens</surname><order>2</order></author><author><firstname>David</firstname><surname>Owens</surname><orcid>0000-0003-1002-1238</orcid><order>3</order></author></authors><documents/><OutputDurs/></rfc1807> |
| spelling |
2017-03-07T16:07:51.6513816 v2 26727 2016-03-09 Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus 2fd4b7c3f82c6d3bd546eff61ff944e9 0000-0003-1002-1238 David Owens David Owens true false 2016-03-09 MEDS Journal Article Diabetes, Obesity and Metabolism 16 7 588 601 31 12 2014 2014-12-31 10.1111/dom.12253 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2017-03-07T16:07:51.6513816 2016-03-09T14:12:01.7325402 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine G. B. Bolli 1 D. R. Owens 2 David Owens 0000-0003-1002-1238 3 |
| title |
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus |
| spellingShingle |
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus David Owens |
| title_short |
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus |
| title_full |
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus |
| title_fullStr |
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus |
| title_full_unstemmed |
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus |
| title_sort |
Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus |
| author_id_str_mv |
2fd4b7c3f82c6d3bd546eff61ff944e9 |
| author_id_fullname_str_mv |
2fd4b7c3f82c6d3bd546eff61ff944e9_***_David Owens |
| author |
David Owens |
| author2 |
G. B. Bolli D. R. Owens David Owens |
| format |
Journal article |
| container_title |
Diabetes, Obesity and Metabolism |
| container_volume |
16 |
| container_issue |
7 |
| container_start_page |
588 |
| publishDate |
2014 |
| institution |
Swansea University |
| doi_str_mv |
10.1111/dom.12253 |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
| document_store_str |
0 |
| active_str |
0 |
| published_date |
2014-12-31T03:51:35Z |
| _version_ |
1851091787749261312 |
| score |
11.089407 |

